Has Rami Eltaraboulsi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,462 in general payments to Rami Eltaraboulsi, MD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rami Eltaraboulsi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rami Eltaraboulsi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rami Eltaraboulsi, MD

Rheumatology · Olney, MDNPI 1427477363

Payments from drug & device makers

$1,462in general payments, 2019–2025

Across 42 payments — averaging $34.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$422
AbbVie$326
AstraZeneca$184
Johnson & Johnson$172
GSK$130
Novartis$130
plus $100 from 3 others

What the payments were for

Food & beverage$1,27988%
Education$18312%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	11	$422
AbbVie	16	$326
AstraZeneca	4	$184
Johnson & Johnson	3	$172
GSK	2	$130
Novartis	1	$130
UCB, Inc.	2	$52
E.r. Squibb & Sons, L.L.C.	2	$36
Organon	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,462 in reported general payments places this provider in the 35th percentile of 173 rheumatology providers in Maryland.

See all rheumatology providers in Maryland →

Medicare billing

Part B allowed, 2024

$2,394,803

Medicare patients

892

Services billed

87,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	25	$185,077
Humira(Cf) PenAdalimumab	16	$165,111
LupkynisVoclosporin	12	$117,082
ForteoTeriparatide	12	$58,480
Febuxostat	21	$4,792
Colchicine	58	$4,603
Hydroxychloroquine Sulfate	88	$4,351
Alendronate Sodium	245	$3,058
MethotrexateMethotrexate Sodium	65	$3,048
Celecoxib	76	$3,029
Leflunomide	27	$2,238
Duloxetine Hcl	55	$1,622
Risedronate Sodium	17	$1,280
Allopurinol	118	$1,153
Diclofenac Sodium	13	$772

Paid to pharmacies, not to this prescriber.

Other rheumatology in Olney

Steven KleinHagerstown$3.4M
Herbert BarafWheaton$1.4M
Paul DemarcoWheaton$1.4M
Thomas Grader BeckBaltimore$1.2M
Michelle PetriBaltimore$1.1M
Laura HummersBaltimore$1M
Alan MatsumotoWheaton$720K
Evan SiegelRockville$624K
Jeffrey PotterWheaton$477K
Donald ThomasGreenbelt$471K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →